Showing 23,074 news articles about People with limited treatment options

Filters Content type: Editors' picks Topic: People with limited treatment options

HIV treatment for people who have a strain of HIV that is resistant to multiple drug classes or who cannot take other HIV medications.

Hepatitis C treatment

New Yorkers on pace to spend $1 B. on Hepatitis C cures

Editor's pick
Capital New York
27 October 2015
New & experimental hepatitis C treatment

NICE Recommends Daklinza (daclatasvir) for Treatment of Certain Patients with Chronic Hepatitis C Genotypes 1, 3 and 4

Editor's pick
Bristol-Myers Squibb press release
16 October 2015
Hepatitis C treatment

Treating 5 percent of hepatitis C patients with new drugs would reduce cost and infections, study shows

Editor's pick
USC News
6 October 2015
Access to healthcare

FixHepC, the buyers club for hepatitis C drug, inundated with inquiries

Editor's pick
Sydney Morning Herald
2 October 2015
Access to healthcare

Hepatitis C drug buyers club aims to set up new source of support

Editor's pick
Sydney Morning Herald
28 September 2015
People who inject drugs

What We Talk About When We Talk About Hepatitis C

Editor's pick
Huffington Post
18 September 2015
Hepatitis C treatment

One in four hepatitis C patients denied initial approval for drug treatment

Editor's pick
Yale News
28 August 2015
People who inject drugs

While Washington Tackles Opioid Abuse Epidemic, Hepatitis C Treatment Remains Unaffordable

Editor's pick
National Journal
19 August 2015
Hepatitis C treatment

Merck Targets Toughest Cases to Gain Hepatitis C Foothold

Editor's pick
Bloomberg
29 July 2015
Hepatitis B

China progresses in hepatitis B vaccination, more treatment effort urged

Editor's pick
Xinhua
27 July 2015
New & experimental hepatitis C treatment

FDA approves Technivie for treatment of chronic hepatitis C genotype 4

Editor's pick
FDA
27 July 2015
New & experimental hepatitis C treatment

FDA is Sued by Advocacy Groups That Want Gilead Hepatitis C Trial Data

Editor's pick
Wall Street Journal (blog)
29 June 2015
Access to healthcare

China rejects Gilead hepatitis C drug patent: advocacy group

Editor's pick
Reuters
19 June 2015
Hepatitis C treatment

NHS accused of delaying access to 'highly tolerable' hepatitis C drugs over cost concerns

Editor's pick
The Independent
17 June 2015
Hepatitis C treatment

NHS England announces 'huge investment' for new hepatitis C treatments

Editor's pick
The Pharmaceutical Journal
16 June 2015
Access to healthcare

Consumers Sue Anthem for Denying Coverage for a Hepatitis C Drug

Editor's pick
Wall Street Journal
28 May 2015
Hepatitis C treatment

The VA's Hepatitis C Problem

Editor's pick
Newsweek
14 May 2015
Hepatitis C treatment

Sanders Asks VA to Break Patents on Gilead and AbbVie Hep C Drugs

Editor's pick
Wall Street Journal (blog)
13 May 2015
Access to healthcare

WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers

Editor's pick
World Health Organization
11 May 2015
Hepatitis C transmission & prevention

Hepatitis C infections soaring, fueled by prescription painkiller abuse

Editor's pick
USA TODAY
11 May 2015
New & experimental hepatitis C treatment

At 50 Cents a Pill, Allergy Drug Could Best $1000 Sovaldi, Harvoni

Editor's pick
Healthline
9 April 2015
Hepatitis C transmission & prevention

World first trials for hepatitis C wonder drug in Sydney's maximum security jails

Editor's pick
Sydney Morning Herald
30 March 2015
Hepatitis C treatment

Bristol-Myers Squibb Co. Is Back in the Hepatitis C Race

Editor's pick
Motley Fool
18 March 2015
Hepatitis C treatment

Gilead's hepatitis C drugs largely cost-effective in US - study

Editor's pick
Reuters
17 March 2015